Canada markets open in 7 hours 15 minutes

Canntab Therapeutics Limited (TBF1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.6250+0.0050 (+0.81%)
As of 8:00AM CET. Market open.
Currency in EUR

Valuation Measures

Market Cap (intraday) 522.74M
Enterprise Value 321.63M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)5.43
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.36
52-Week Change 396.77%
S&P500 52-Week Change 333.30%
52 Week High 30.7150
52 Week Low 30.1590
50-Day Moving Average 30.5564
200-Day Moving Average 30.4705

Share Statistics

Avg Vol (3 month) 3190
Avg Vol (10 day) 3N/A
Shares Outstanding 535.45M
Float 34.8M
% Held by Insiders 111.63%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:200
Last Split Date 3Apr. 20, 2018

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends May 31, 2020
Most Recent Quarter (mrq)Nov. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-47.84%
Return on Equity (ttm)-121.57%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)124.78k
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-0.0870
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)17.70
Current Ratio (mrq)1.70
Book Value Per Share (mrq)0.12

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A